Cagent Vascular Initiates Patient Enrollment in the Serranator® vs. POBA OCT Study at Columbia University Medical Center

Study Seeks to Confirm Benefits of Cagent’s Unique Serration Balloon Angioplasty Technology vs. Plain Old Balloon Angioplasty (POBA) in treating Peripheral Artery Disease (PAD) in Below-the-Knee Arteries. WAYNE, Penn., [April 10, 2025] – Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, announced its first patient enrollment of the Serranator vs.